NoCamels publishes article on the benefits of nociception monitoring with the NOL Technology April 16, 2023
FDA authorizes marketing of Medasense’s NOL (nociception level index) technology through a De Novo grant February 23, 2023
New study shows that the odds of suffering severe post-operative pain are six times lower with NOL January 24, 2023